Analysts expect NewLink Genetics Corporation (NASDAQ:NLNK) to report $-0.55 EPS on May, 3.They anticipate $0.17 EPS change or 23.61% from last quarter’s $-0.72 EPS. After having $-0.37 EPS previously, NewLink Genetics Corporation’s analysts see 48.65% EPS growth. The stock increased 1.11% or $0.05 during the last trading session, reaching $4.54. About 1.20 million shares traded or 2.39% up from the average. NewLink Genetics Corporation (NASDAQ:NLNK) has declined 65.28% since April 24, 2017 and is downtrending. It has underperformed by 76.83% the S&P500.
Gamestop Corp (GME) investors sentiment increased to 1.46 in 2017 Q4. It’s up 0.39, from 1.07 in 2017Q3. The ratio is positive, as 156 active investment managers opened new or increased stock positions, while 107 sold and reduced stakes in Gamestop Corp. The active investment managers in our database now have: 108.87 million shares, up from 100.21 million shares in 2017Q3. Also, the number of active investment managers holding Gamestop Corp in top ten stock positions was flat from 1 to 1 for the same number . Sold All: 37 Reduced: 70 Increased: 100 New Position: 56.
Ratings analysis reveals 57% of GameStop’s analysts are positive. Out of 7 Wall Street analysts rating GameStop, 4 give it “Buy”, 1 “Sell” rating, while 2 recommend “Hold”. The lowest target is $20.67 while the high is $35.0. The stock’s average target of $29.11 is 120.53% above today’s ($13.2) share price. GME was included in 7 notes of analysts from November 2, 2016. On Friday, January 13 the stock rating was downgraded by Macquarie Research to “Neutral”. The stock has “Buy” rating by Mizuho on Friday, December 23. Loop Capital initiated it with “Buy” rating and $32.0 target in Wednesday, December 7 report. The rating was downgraded by Piper Jaffray on Wednesday, November 2 to “Neutral”. Benchmark maintained it with “Sell” rating and $20.67 target in Wednesday, November 2 report. The company was upgraded on Thursday, December 29 by Standpoint Research. The rating was maintained by Telsey Advisory on Thursday, November 3 with “Outperform”.
Permit Capital Llc holds 6.76% of its portfolio in GameStop Corp. for 700,000 shares. Towle & Co owns 1.84 million shares or 3.26% of their US portfolio. Moreover, Sprott Inc. has 1.76% invested in the company for 335,000 shares. The New York-based Stuyvesant Capital Management has invested 1.76% in the stock. S&T Bank Pa, a Pennsylvania-based fund reported 512,417 shares.
GameStop Corp. operates as an omnichannel video game retailer. The company has market cap of $1.34 billion. It sells new and pre-owned video game hardware; video game software; pre-owned and value video game products; video game accessories, such as controllers, gaming headsets, virtual reality products, memory cards, and other add-ons; and digital products, including downloadable content, network points cards, prepaid digital and subscription cards, and digitally downloadable software. It has a 38.82 P/E ratio. The firm also sells mobile and consumer electronics, including wireless services and products, and accessories, as well as new and pre-owned smart phones; personal computer entertainment software in various genres, including sports, action, strategy, adventure/role playing, and simulation; and strategy guides, magazines, and interactive game figures.
The stock increased 2.48% or $0.32 during the last trading session, reaching $13.2. About 3.69M shares traded. GameStop Corp. (GME) has declined 33.43% since April 24, 2017 and is downtrending. It has underperformed by 44.98% the S&P500.
Analysts await GameStop Corp. (NYSE:GME) to report earnings on May, 24. They expect $0.40 EPS, down 36.51% or $0.23 from last year’s $0.63 per share. GME’s profit will be $40.64M for 8.25 P/E if the $0.40 EPS becomes a reality. After $2.02 actual EPS reported by GameStop Corp. for the previous quarter, Wall Street now forecasts -80.20% negative EPS growth.
Among 6 analysts covering NewLink Genetics (NASDAQ:NLNK), 1 have Buy rating, 0 Sell and 5 Hold. Therefore 17% are positive. NewLink Genetics had 21 analyst reports since March 23, 2016 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, August 24 by Jefferies. The firm has “Buy” rating given on Friday, September 8 by Jefferies. The stock of NewLink Genetics Corporation (NASDAQ:NLNK) has “Buy” rating given on Sunday, June 4 by Cantor Fitzgerald. The firm has “Buy” rating by Robert W. Baird given on Friday, October 13. As per Monday, April 9, the company rating was downgraded by Cantor Fitzgerald. The stock of NewLink Genetics Corporation (NASDAQ:NLNK) has “Outperform” rating given on Friday, September 8 by Robert W. Baird. The rating was maintained by Jefferies with “Buy” on Friday, November 3. Bank of America maintained it with “Buy” rating and $18 target in Friday, March 2 report. The stock has “Neutral” rating by Robert W. Baird on Monday, April 9. The stock has “Hold” rating by Jefferies on Thursday, June 8.
Investors sentiment increased to 1.51 in 2017 Q4. Its up 0.29, from 1.22 in 2017Q3. It increased, as 22 investors sold NewLink Genetics Corporation shares while 21 reduced holdings. 28 funds opened positions while 37 raised stakes. 23.56 million shares or 27.79% more from 18.44 million shares in 2017Q3 were reported. Federated Investors Pa reported 17,370 shares stake. Panagora Asset Mngmt Incorporated stated it has 0% in NewLink Genetics Corporation (NASDAQ:NLNK). Eqis Capital Mngmt has invested 0.01% in NewLink Genetics Corporation (NASDAQ:NLNK). Moore Management Limited Partnership has invested 0.01% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK). Millennium Limited Com owns 2.35 million shares for 0.03% of their portfolio. Ameritas Invest Prns Inc stated it has 0% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK). Trexquant Investment Limited Partnership has 0.05% invested in NewLink Genetics Corporation (NASDAQ:NLNK) for 60,917 shares. Susquehanna Intl Grp Llp holds 99,862 shares. Buckingham Asset Mgmt Ltd Llc has 0.03% invested in NewLink Genetics Corporation (NASDAQ:NLNK). Ny State Common Retirement Fund holds 0% in NewLink Genetics Corporation (NASDAQ:NLNK) or 21,800 shares. Hudson Bay Capital Management L P owns 125,000 shares or 0.02% of their US portfolio. Amundi Pioneer Asset Management Incorporated holds 0% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK) for 202,200 shares. Invesco holds 0% or 14,355 shares. Cubist Systematic Strategies Limited Company holds 0.01% of its portfolio in NewLink Genetics Corporation (NASDAQ:NLNK) for 21,141 shares. Tower Research Cap Llc (Trc) holds 72 shares or 0% of its portfolio.